Global Circular RNA Therapy Market Growth 2024-2030

Global Circular RNA Therapy Market Growth 2024-2030

Circular RNA (circRNA) is a new type of RNA that is different from traditional linear RNA. It has a closed ring structure and is abundantly present in the eukaryotic transcriptome. Most circRNAs are composed of exon sequences, which are conserved in different species and have expression specificity in tissues and different developmental stages. Because circRNA is insensitive to nucleases, it is more stable than linear RNA, which gives circRNA a clear advantage in the development and application of new clinical diagnostic markers. In addition, recent studies have shown that circRNAs act as miRNA sponges in different species and are called competitive endogenous RNAs (ceRNAs), which can competitively bind to miRNAs and thereby regulate the expression of target genes. This shows that circRNA may play a very important role in disease regulation by competitively binding to disease-related miRNAs.

The global Circular RNA Therapy market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Circular RNA Therapy Industry Forecast” looks at past sales and reviews total world Circular RNA Therapy sales in 2023, providing a comprehensive analysis by region and market sector of projected Circular RNA Therapy sales for 2024 through 2030. With Circular RNA Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Circular RNA Therapy industry.

This Insight Report provides a comprehensive analysis of the global Circular RNA Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Circular RNA Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Circular RNA Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Circular RNA Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Circular RNA Therapy.

United States market for Circular RNA Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Circular RNA Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Circular RNA Therapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Circular RNA Therapy players cover Orna Therapeutics, Torque Bio, Chimera Therapeutics, CirCode, Curemedbio, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Circular RNA Therapy market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Preventive Medicine
Medicine

Segmentation by Application:
Infectious Diseases
Cancer
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Orna Therapeutics
Torque Bio
Chimera Therapeutics
CirCode
Curemedbio
Sail Biomedicines
Orbital Therapeutics
Therorna

Key Questions Addressed in this Report

What is the 10-year outlook for the global Circular RNA Therapy market?

What factors are driving Circular RNA Therapy market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Circular RNA Therapy market opportunities vary by end market size?

How does Circular RNA Therapy break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.